Eldrin F. Lewis

Active 2001–2025

131
Papers
32,385
Citations
74
h-index
121
i10-index

Citations

Citations per year for Eldrin F. Lewis1996: 2 citations2000: 1 citations2002: 2 citations2003: 10 citations2004: 9 citations2005: 49 citations2006: 42 citations2007: 58 citations2008: 33 citations2009: 35 citations2010: 58 citations2011: 84 citations2012: 100 citations2013: 149 citations2014: 132 citations2015: 157 citations2016: 198 citations2017: 259 citations2018: 265 citations2019: 903 citations2020: 1,149 citations2021: 1,275 citations2022: 1,174 citations2023: 897 citations2024: 1,725 citations2025: 1,232 citations2026: 59 citations1997–1999: no citations, so these years are not shown2001: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,819 citing papers, 21.4% of this breakdownChina: 1,402 citing papers, 7.8% of this breakdownUnited Kingdom: 1,340 citing papers, 7.5% of this breakdownItaly: 974 citing papers, 5.5% of this breakdownGermany: 886 citing papers, 5% of this breakdownCanada: 882 citing papers, 4.9% of this breakdownNetherlands: 628 citing papers, 3.5% of this breakdownFrance: 586 citing papers, 3.3% of this breakdownAustralia: 517 citing papers, 2.9% of this breakdownSpain: 486 citing papers, 2.7% of this breakdownJapan: 468 citing papers, 2.6% of this breakdownSweden: 427 citing papers, 2.4% of this breakdown
0%21.4%Other 30.5%

Fields

  • Medicine81.2%
  • Biochemistry, Genetics and Molecular Biology7.6%
  • Immunology and Microbiology3.3%
  • Engineering2.1%
  • Social Sciences1%
  • Health Professions1%
  • Other3.8%

Topics

  • Heart Failure Treatment and Management8.3%
  • Cardiovascular Function and Risk Factors6.8%
  • Diabetes Treatment and Management6%
  • Lipoproteins and Cardiovascular Health1.9%
  • Cardiac pacing and defibrillation studies1.8%
  • Erythropoietin and Anemia Treatment1.6%
  • Other73.6%

Coauthors

All papers

Open in search
  1. Atherosclerosis

    Authors: , , , , , , , - Nature Reviews Disease Primers 2019 cited by 2,999

  2. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2023 cited by 1,653

  3. A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2023 cited by 1,088

  4. Spironolactone for Heart Failure with Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 cited by 2,730

  5. Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

    Authors: , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 cited by 2,338

  6. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul Burton, Laura Mauri, Christopher M. O’Connor, Marc A. Pfeffer, Hung Hung, Norman Stockbridge, Bernard Chaitman, Robert J. Temple - Circulation 2018 cited by 713

  7. Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial

    Authors: , , , , , , , , , , , , , , , , , , , , - Circulation 2014 cited by 1,040

  8. Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association

    Authors: , , , , , , , , , , , - Circulation 2018 cited by 914

  9. Angiotensin Receptor–Neprilysin Inhibition in Acute Myocardial Infarction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eugene Braunwald - New England Journal of Medicine 2021 cited by 295

  10. Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association

    Authors: , , , , , , , , , , , , , , , - Circulation 2016 cited by 869

  11. Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction

    Authors: , , , , , , , , , , , , - European Heart Journal 2015 cited by 525

  12. A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

    Authors: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2009 cited by 2,076

  13. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul Burton, Laura Mauri, Christopher M. O’Connor, Marc A. Pfeffer, Hung Hung, Norman Stockbridge, Bernard Chaitman, Robert J. Temple, Heather D. Fitter, Kachikwu Illoh, Kenneth J. Cavanaugh, Benjamin M. Scirica, Ilan Irony, Rachel E. Brown Kichline, Jonathan G. Levine, Anna Park, Leonard Sacks, Ana Szarfman, Ellis F. Unger, Lori Ann Wachter, Bram Zuckerman, Yale Mitchel, Douglas Peddicord, Thomas Shook, Bron Kisler, Charles L. Jaffe, Rhonda Bartley, David L. DeMets, MariJo Mencini, Cheri Janning, Steve Bai, John Lawrence, Ralph B. D’Agostino, Stuart Pocock - Journal of the American College of Cardiology 2018 cited by 322

  14. Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 cited by 238

  15. Prioritizing Functional Capacity as a Principal End Point for Therapies Oriented to Older Adults With Cardiovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association

    Authors: , , , , , , , , , , , , , - Circulation 2017 cited by 309

  16. The Frailty Syndrome and Outcomes in the TOPCAT Trial

    Authors: , , , , , , , , , - European Journal of Heart Failure 2018 cited by 172

  17. Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 cited by 197

  18. Race and Ethnicity in Heart Failure

    Authors: , , , , , , - Journal of the American College of Cardiology 2021 cited by 89

  19. Improving representativeness in trials: a call to action from the Global Cardiovascular Clinical Trialists Forum

    Authors: , , , , , , , , , , , , - European Heart Journal 2023 cited by 74

  20. Stenting and Medical Therapy for Atherosclerotic Renal-Artery Stenosis

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2013 cited by 1,007

  21. Spironolactone Metabolites in TOPCAT — New Insights into Regional Variation

    Authors: , , , , , , , , , , , - New England Journal of Medicine 2017 cited by 267

  22. Identification of Racial Inequities in Access to Specialized Inpatient Heart Failure Care at an Academic Medical Center

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Omar Bayomy, Julia Beamesderfer, Nora V. Becker, David D. Berg, Berman Adam N., Steven M. Blum, Alexander P. Boardman, Kaeleen A. Boden, Robert A. Bonacci, Sarah Brown, Kirsti A. Campbell, Siobhan Case, Emily Cetrone, Alexandra Charrow, David Chiang, Devin Clark, Aarón Cohen, A. Feder Cooper, Tomas Cordova, C. Nicholas Cuneo, Alsina Alejandro de Feria, Karen Deffenbacher, Ersilia M. DeFilippis, Geneva DeGregorio, Aaron J. Deutsch, Bradford Diephuis, Sanjay Divakaran, Peter B. Dorschner, Nicholas S. Downing, Caitlin Drescher, Kristin M. D’Silva, Peter J. Dunbar, David Duong, Sarah E. Earp, Christine Eckhardt, Scott A. Elman, Ross N. England, Kay Everett, Natalie O. Fedotova, Tamara Feingold-Link, Mark Ferreira, Herrick Fisher, Patricia K. Foo, Michael B. Foote, Idalid Franco, Thomas Gilliland, Jacqueline Greb, Katherine J. Greco, Sungat K. Grewal, Benjamin Grin, Matthew E. Growdon, Brendan J. Guercio, Cynthia K. Hahn, Brian W. Hasselfeld, Erika J Haydu, Zachary Hermes, Gordon J. Hildick-Smith, Zachary E. Holcomb, Kathryn B. Holroyd, Laura Horton, George T.‐J. Huang, Stanley Jablonski, Douglas Jacobs, Nina Jain, Sohan Japa, Richard Joseph, Mariya Kalashnikova, Neil Kalwani, Daniel G. Kang, Abraar Karan and 128 more - Circulation Heart Failure 2019 cited by 186

  23. Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , , , - JAMA 2021 cited by 145

  24. Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes

    Authors: , , , , , , , , , , , , , , , , - JAMA 2004 cited by 1,331